180 related articles for article (PubMed ID: 12384357)
1. Pharmacokinetics of ertapenem in healthy young volunteers.
Majumdar AK; Musson DG; Birk KL; Kitchen CJ; Holland S; McCrea J; Mistry G; Hesney M; Xi L; Li SX; Haesen R; Blum RA; Lins RL; Greenberg H; Waldman S; Deutsch P; Rogers JD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3506-11. PubMed ID: 12384357
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intramuscularly administered ertapenem.
Musson DG; Majumdar A; Birk K; Holland S; Wickersham P; Li SX; Mistry G; Fisher A; Waldman S; Greenberg H; Deutsch P; Rogers JD
Antimicrob Agents Chemother; 2003 May; 47(5):1732-5. PubMed ID: 12709348
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects.
Musson DG; Majumdar A; Holland S; Birk K; Xi L; Mistry G; Sciberras D; Muckow J; Deutsch P; Rogers JD
Antimicrob Agents Chemother; 2004 Feb; 48(2):521-4. PubMed ID: 14742204
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J
Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521
[TBL] [Abstract][Full Text] [Related]
5. Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma.
Musson DG; Birk KL; Kitchen CJ; Zhang J; Hsieh JY; Fang W; Majumdar AK; Rogers JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):1-9. PubMed ID: 12450519
[TBL] [Abstract][Full Text] [Related]
6. Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers.
Laethem T; De Lepeleire I; McCrea J; Zhang J; Majumdar A; Musson D; Rogers D; Li S; Guillaume M; Parneix-Spake A; Deutsch P
Antimicrob Agents Chemother; 2003 Apr; 47(4):1439-42. PubMed ID: 12654688
[TBL] [Abstract][Full Text] [Related]
7. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
Pletz MW; Rau M; Bulitta J; De Roux A; Burkhardt O; Kruse G; Kurowski M; Nord CE; Lode H
Antimicrob Agents Chemother; 2004 Oct; 48(10):3765-72. PubMed ID: 15388432
[TBL] [Abstract][Full Text] [Related]
8. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
Burkhardt O; Brunner M; Schmidt S; Grant M; Tang Y; Derendorf H
J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
[TBL] [Abstract][Full Text] [Related]
9. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T
J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents.
Abdel-Rahman SM; Kearns GL; Topelberg S; Jacobs RF; Mistry GC; Majumdar A; Xu Y; Wagner JA; Kitchen CJ; Groff M; Herman G; Blumer JL
Pediatr Infect Dis J; 2010 Dec; 29(12):1072-6. PubMed ID: 20571461
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients.
Hsaiky LM; Salinitri FD; Wong J; Jennings ST; Desai NH; Lobkovich AM; Cha R
Nephrol Dial Transplant; 2019 Oct; 34(10):1766-1772. PubMed ID: 29992286
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers.
Wiskirchen DE; Housman ST; Quintiliani R; Nicolau DP; Kuti JL
Pharmacotherapy; 2013 Mar; 33(3):266-74. PubMed ID: 23400916
[TBL] [Abstract][Full Text] [Related]
14. Unbound fraction of ertapenem in intensive care unit patients.
Liebchen U; Kratzer A; Wicha SG; Kees F; Kloft C; Kees MG
J Antimicrob Chemother; 2014 Nov; 69(11):3108-11. PubMed ID: 24962030
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
Mistry GC; Majumdar AK; Swan S; Sica D; Fisher A; Xu Y; Hesney M; Xi L; Wagner JA; Deutsch PJ
J Clin Pharmacol; 2006 Oct; 46(10):1128-38. PubMed ID: 16988201
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Saux MC; Gordien JB; Allaouchiche B
Intensive Care Med; 2006 Dec; 32(12):2059-62. PubMed ID: 17039351
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.
Zhou J; Sulaiman Z; Llorin RM; Hee KH; Lee LS; Lye DC; Fisher DA; Tam VH
J Antimicrob Chemother; 2014 Sep; 69(9):2517-21. PubMed ID: 24797063
[TBL] [Abstract][Full Text] [Related]
18. Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.
Wong BK; Sahly Y; Mistry G; Waldman S; Musson D; Majumdar A; Xu X; Yu S; Lin JH; Singh R; Holland S
Xenobiotica; 2004 Apr; 34(4):379-89. PubMed ID: 15268982
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
Burkhardt O; Hafer C; Langhoff A; Kaever V; Kumar V; Welte T; Haller H; Fliser D; Kielstein JT
Nephrol Dial Transplant; 2009 Jan; 24(1):267-71. PubMed ID: 18723863
[TBL] [Abstract][Full Text] [Related]
20. Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.
Eckburg PB; Lister T; Walpole S; Keutzer T; Utley L; Tomayko J; Kopp E; Farinola N; Coleman S
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
